
Dyne Therapeutics (DYN) P/E Ratio
P/E Ratio as of Jun 13, 2025: -4.01
Average-3.61
Median-3.49
Minimum-4.12
Maximum-3.25
-4.01
Past Month-0.74 (22.63%)
The P/E ratio for Dyne Therapeutics (DYN) is -4.01 as of Jun 13, 2025. This represents a decrease of -40.68% compared to its 12-month average P/E ratio of -6.76. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Dyne Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Dyne Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Dyne Therapeutics to industry peers.
Dyne Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Dyne Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Dyne Therapeutics to industry peers.
Dyne Therapeutics (DYN) P/E Ratio Insights
See Dyne Therapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Dyne Therapeutics (DYN)
Order type
Buy in
Order amount
Est. shares
0 shares
Dyne Therapeutics (DYN) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $12.70 | -3.54 |
May 1, 2025 | $11.99 | -3.58 |
Apr 1, 2025 | $9.23 | -2.75 |
Mar 3, 2025 | $12.32 | -3.68 |
Feb 3, 2025 | $13.87 | -3.89 |
Jan 2, 2025 | $25.46 | -7.15 |
Dyne Therapeutics (DYN) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -4.01 | -39.33% |
2024 | -6.61 | +78.65% |
2023 | -3.70 | +11.78% |
2022 | -3.31 | -18.67% |
2021 | -4.07 | — |
FAQs About Dyne Therapeutics (DYN) P/E ratio
The latest P/E ratio of Dyne Therapeutics (DYN) is -4.01, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Dyne Therapeutics’s last 12-month average P/E ratio is -6.76, compared to its current P/E ratio of -4.01. This reflects a decrease of -40.68%.
Dyne Therapeutics’s current P/E ratio of -4.01 is lower than its last 12-month average P/E of -6.76. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Dyne Therapeutics’s average P/E ratio over the last 3 years is -4.93. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Dyne Therapeutics’s average P/E ratio over the last 5 years is -3.87. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.